|
US2014065144A1
|
|
Use of il-20 antagonists for promoting bone fracture healing
|
|
US8603470B1
|
|
Use of IL-20 antagonists for treating liver diseases
|
|
US2014044715A1
|
|
Treating allergic airway disorders using anti-IL-20 receptor antibodies
|
|
US2013315893A1
|
|
Humanized anti-IL-20 antibody and uses thereof
|
|
US2011064731A1
|
|
Methods for treating rheumatoid arthritis and osteoporosis with anti-IL-20 antibodies
|
|
US2012034225A1
|
|
Suppressing Bone Loss with Anti-IL-19 Antibody
|
|
US2012034224A1
|
|
Treating Rheumatoid Arthritis with Anti-IL-19 Antibody
|
|
US2011305698A1
|
|
Treating breast cancer and inhibiting cancer-associated bone loss with anti-IL-20 antibody
|
|
US2011305699A1
|
|
Treating Oral Cancer with Anti-IL-20 Antibody
|
|
WO2007081465A2
|
|
Antibodies to interleukin-20 and method for inhibiting interleukin-20 induced cell proliferation
|
|
US2004076606A1
|
|
Methods of modulating inflammation by administration of interleukin-19 and inhibitors of IL-19 binding
|
